Trial record 1 of 2 for:    cerulean
Previous Study | Return to List | Next Study

CRLX101 Plus Bevacizumab in Advanced RCC

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT01625936
Recruitment Status : Unknown
Verified October 2015 by Abramson Cancer Center of the University of Pennsylvania.
Recruitment status was:  Active, not recruiting
First Posted : June 22, 2012
Last Update Posted : July 20, 2016
Information provided by (Responsible Party):
Abramson Cancer Center of the University of Pennsylvania

No Study Results Posted on for this Study
  Recruitment Status : Unknown
  Actual Primary Completion Date : June 2014
  Study Completion Date : No date given